Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. P.P. (Peter) De Deyn

Publications

Administration of a TNF receptor 2 agonist improves neuropathology and cognitive functions in an Alzheimer’s disease model

Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

Clinical variables contributing to the identification of biologically defined subgroups within cognitively unimpaired and mild cognitive impairment individuals

Epigenetics and Down syndrome

Financial capability of people living with Parkinson’s disease: A case-control study

Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases—A Systematic Review

Metabolic Syndrome Status Changes and Cognitive Functioning: Insights from the Lifelines Cohort Study

Small vessel disease burden and functional brain connectivity in mild cognitive impairment

Activation of TNF Receptor 2 improves synaptic plasticity and enhances amyloid-β clearance in an Alzheimer's disease mouse model with humanized TNF Receptor 2

Association between Low Vitamin D Status, Serotonin, and Clinico-Biobehavioral Parameters in Alzheimer’s Disease

Read more

Press/media

Lagere schatting aantal dementerenden in Europa tot 2050

Dementietafels: 'Er is een enorme honger naar informatie'

Down en dwars - of dement